Abstract: A method for sharing data in a transmitting-side electronic device communicating with a receiving-side electronic device is provided. The method includes connecting a voice call with the receiving-side electronic device; obtaining a sharing object to be shared with the receiving-side electronic device; and transmitting data corresponding to the sharing object to the receiving-side electronic device through a data session formed based on information related to the voice call.

Abstract: A case opening apparatus is disclosed. In some implementations, the case opening apparatus may include a suction portion including a first suction portion configured to suction an upper portion of a case of a battery cell being in a folded state and a second suction portion configured to suction a lower portion of the case, and a rotation driving portion configured to open the inside of the case by rotating the first suction portion.

Abstract: A carrier includes a base assembly movably coupled to a transfer rail, a seating plate disposed above the base assembly and having a battery cell seated on an upper surface thereof, a pressurizing and fixing portion for fixing the battery cell to the seating plate by pressurizing the battery cell, and an elastic member for pressurizing the pressurizing and fixing portion toward the seating plate side, wherein the pressurizing and fixing portion is coupled to the base assembly to move in a first direction, which is a horizontal direction, and a second direction, which is a vertical direction.

Abstract: A carrier includes a base assembly movably coupled to a transfer rail, a seating plate disposed above the base assembly and having a battery cell seated on an upper surface thereof, a pressurizing and fixing portion for fixing the battery cell to the seating plate by pressurizing the battery cell, and an elastic member for pressurizing the pressurizing and fixing portion toward the seating plate side, wherein the pressurizing and fixing portion is coupled to the base assembly to move in a first direction, which is a horizontal direction, and a second direction, which is a vertical direction.

Abstract: A case opening apparatus is disclosed. In some implementations, the case opening apparatus may include a suction portion including a first suction portion configured to suction an upper portion of a case of a battery cell being in a folded state and a second suction portion configured to suction a lower portion of the case, and a rotation driving portion configured to open the inside of the case by rotating the first suction portion.

Abstract: A sealing apparatus is disclosed. In some implementations, the sealing apparatus includes a process chamber having an internal space, a cell loading portion configured to load a plurality of battery cells and enter the internal space of the process chamber, a plurality of sealing units disposed in the internal space of the process chamber, the plurality of sealing units configured to partially seal the battery cells, respectively, and a driving portion configured to move the plurality of sealing units such that the plurality of sealing units come into contact with the plurality of battery cells, respectively.

Abstract: The present invention relates to a method of treating cancer by administering allostatine in combination with a chemotherapeutic agent. The combination therapy provides improved therapeutic efficacy for treatment of solid tumors, including pancreatic cancer, colorectal cancer and ovarian cancer. Further provided herein is a pharmaceutical composition for use in the combination therapy.

Abstract: The present invention relates to a method of treating cancer by administering alloferon in combination with a microtubule-stabilizing agent. The combination therapy provides improved therapeutic efficacy for treatment of solid tumors, including pancreatic cancer. Further provided herein includes a pharmaceutical composition for use in the combination therapy.

Abstract: The present invention relates to a pharmaceutical composition for the inhibition of cancer metastasis, more precisely, a novel pharmaceutical composition against cancer metastasis comprising lipocalin 2 protein, a gene encoding the protein, an expression vector containing the gene or cells transfected with the expression vector as an effective ingredient, a method for the inhibition of cancer metastasis using the composition, a diagnostic kit for the prediction of cancer metastasis, a method for the selection of a metastasis risk group using the kit, a novel pharmaceutical composition for the inhibition of cancer growth and a method for the inhibition of cancer growth using the same. The pharmaceutical composition of the present invention specifically inhibits cancer metastasis, so that it can improve the effect of cancer treatment dramatically.

Abstract: The present invention relates to an LK8-Fc fusion protein, which has increased angiogenesis inhibitory activity and in vivo stability. More specifically, relates to an LK8-Fc fusion protein in which an LK8 protein having angiogenesis inhibitory activity is fused with the Fc region of human immunoglobulin IgG1, as well as a composition for treating cancer, which contains the fusion protein. The LK8-Fc fusion protein has not only angiogenesis inhibitory activity leading to anticancer and metastasis inhibitory activities, but also a very long in vivo half-life, and thus can be used as a more efficient and economic cancer therapeutic agent or cancer inhibitor.

Abstract: The present invention relates to a pharmaceutical composition for the inhibition of cancer metastasis, more precisely, a novel pharmaceutical composition against cancer metastasis comprising lipocalin 2 protein, a gene encoding the protein, an expression vector containing the gene or cells transfected with the expression vector as an effective ingredient, a method for the inhibition of cancer metastasis using the composition, a diagnostic kit for the prediction of cancer metastasis, a method for the selection of a metastasis risk group using the kit, a novel pharmaceutical composition for the inhibition of cancer growth and a method for the inhibition of cancer growth using the same. The pharmaceutical composition of the present invention specifically inhibits cancer metastasis, so that it can improve the effect of cancer treatment dramatically.

Abstract: The present application discloses a method of reducing tumor growth that includes contacting the tumor with a tumor growth reducing effective amount of a composition comprising LK8 or LK68 protein or a functionally equivalent amino acid variant thereof and a pharmaceutically acceptable carrier thereof to a subject having tumor.

Abstract: The present invention relates to an anticancer or an anti-metastatic agent for gene therapy, more precisely, an anticancer or an anti-metastatic agent for gene therapy containing a gene carrier or cells harboring human apolipoprotein (a) kringle KIV9-KIV10-KV (LK68) or KV (LK8) gene as an effective ingredient, and a treatment method for cancer using the same. The agent for gene therapy of the present invention has an inhibiting effect on the growth and the metastasis of a tumor, so it can be effectively used for the prevention and the treatment of various solid tumors as a metastasis inhibitor or a therapeutic agent for primary tumors.

Abstract: The present application discloses a method of reducing tumor growth that includes contacting the tumor with a tumor growth reducing effective amount of a composition comprising LK8 or LK68 protein or a functionally equivalent amino acid variant thereof and a pharmaceutically acceptable carrier thereof to a subject having tumor.